A detailed history of Axq Capital, LP transactions in Natera, Inc. stock. As of the latest transaction made, Axq Capital, LP holds 2,888 shares of NTRA stock, worth $462,830. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,888
Previous 7,566 61.83%
Holding current value
$462,830
Previous $819 Million 55.25%
% of portfolio
0.11%
Previous 0.19%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$97.75 - $129.67 $457,274 - $606,596
-4,678 Reduced 61.83%
2,888 $367 Million
Q2 2024

Aug 13, 2024

BUY
$85.28 - $112.6 $645,228 - $851,931
7,566 New
7,566 $819 Million
Q4 2023

Feb 13, 2024

BUY
$37.55 - $62.64 $172,730 - $288,144
4,600 New
4,600 $288 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.5B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Axq Capital, LP Portfolio

Follow Axq Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Axq Capital, LP with notifications on news.